Why Patients Consider Moving from 5mg Mounjaro to Wegovy
Online Prescription Process for 5mg Mounjaro to Wegovy Transition
Transitioning from 5mg Mounjaro to Wegovy requires careful clinical oversight, which our online prescription service provides through comprehensive assessment. Our 3-minute clinical questionnaire evaluates your current treatment response, medical history, and suitability for semaglutide therapy. Licensed UK prescribers within our GPhC-registered pharmacy (#9012878) review every case individually, ensuring safe medication transitions. The assessment covers contraindications, drug interactions, and optimal dosing protocols for your specific circumstances.
Unlike traditional GP appointments that may take weeks to arrange, our online prescription process delivers results within 3 working days as standard, or 24 hours with express review. This efficiency proves particularly valuable when managing medication transitions or addressing supply interruptions. Your prescriber will determine the appropriate starting dose based on your current 5mg Mounjaro experience, potentially allowing modified dose escalation schedules where clinically appropriate.
Wegovy Pricing and Bundle Options for Mounjaro Switchers
EverydayMeds offers transparent pricing for patients transitioning from 5mg Mounjaro to Wegovy, with starter doses from £79.99 after applying new customer code FIRST40 at checkout. Our Progress Duo bundle (0.5mg & 1mg) costs £189.99, ideal for patients whose prescriber recommends accelerated escalation based on prior tirzepatide experience. The Elevate Trio bundle (1mg, 1.7mg & 2.4mg) provides three months of progressive dosing for £499.99. Returning customers benefit from code DOSE25, maintaining competitive pricing throughout their treatment journey.
Bundle pricing reflects convenience rather than savings, ensuring uninterrupted supply during your transition period. Our Ultimate Stability Trio offers three months of maintenance 2.4mg dosing for £649.99, perfect for established patients. Storage advantages become particularly relevant for bundle purchases, as Wegovy's 6-week room temperature stability surpasses Mounjaro's 21-day limit, reducing waste from storage mishaps.
Clinical Evidence Supporting 5mg Mounjaro to Wegovy Switches
The STEP trial programme demonstrates semaglutide's robust efficacy profile, with STEP 1 showing approximately 15% average weight loss at 68 weeks when used alongside diet and exercise modifications (Wilding et al., NEJM, 2021). STEP 5 data confirms sustained results at two years, with patients maintaining approximately 15.2% weight reduction. These outcomes may provide reassurance for patients considering transition from tirzepatide therapy.
The SELECT cardiovascular outcomes trial revealed 20% reduction in major cardiovascular events (HR 0.80), adding cardioprotective benefits beyond weight management. This evidence base may influence prescriber decisions when evaluating 5mg Mounjaro to Wegovy transitions, particularly for patients with cardiovascular risk factors.
How Wegovy Works Differently from Mounjaro
Wegovy contains semaglutide, a selective GLP-1 receptor agonist that mimics natural incretin hormones produced in your intestines after eating. This mechanism differs from Mounjaro's dual GIP/GLP-1 approach, focusing exclusively on GLP-1 pathways to reduce appetite and promote satiety. Semaglutide works on brain appetite centres, particularly in the hypothalamus, reducing food cravings and extending feelings of fullness after smaller meals. The once-weekly injection schedule maintains consistent therapeutic levels, supporting sustained appetite regulation throughout your treatment. Clinical studies suggest this targeted GLP-1 approach may suit patients who experienced specific side effects or insufficient response with dual-agonist therapy.
Streamlined Ordering Process for Wegovy Prescriptions
Our online prescription system simplifies access to Wegovy for patients considering transition from 5mg Mounjaro therapy. Complete our 3-minute clinical assessment covering medical history, current medications, treatment goals, and previous injection therapy experience. Licensed prescribers review submissions within 3 working days (express 24-hour service available), with email notifications confirming approval status. Once prescribed, your Wegovy ships via next-day cold-chain delivery, maintaining 2-8°C temperature control throughout transit. Our pharmacy team provides injection guidance and dose escalation schedules, ensuring smooth transition from your current treatment.
Storage and Practical Advantages When Switching to Wegovy
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable for 6 weeks at room temperature below 30°C once removed from refrigeration, versus Mounjaro's 21-day limit. This advantage proves particularly valuable for frequent travellers or patients with limited refrigerator space. The FlexTouch pen design provides intuitive injection experience with audible click confirmation and dose counter visibility. Standard dose escalation follows a 16-week schedule: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), then 2.4mg maintenance dosing. Your prescriber may modify this schedule based on your prior 5mg Mounjaro experience and tolerance profile.
Transition Considerations for 5mg Mounjaro to Wegovy Patients
Patients switching from 5mg Mounjaro to Wegovy require individualised transition protocols, as direct dose equivalency doesn't exist between tirzepatide and semaglutide. Your prescriber will evaluate your current response, side effect profile, and treatment duration when determining optimal Wegovy starting doses. Some patients may begin at 0.5mg rather than 0.25mg, depending on injection therapy experience and tolerance history. Timing the switch appropriately minimises potential gap periods that could affect appetite control.
Our clinical team coordinates transition timing with your current prescription cycle where possible, ensuring seamless changeover. The prescription-only medicine status requires fresh clinical assessment even for established injection therapy patients, confirming continued suitability and identifying any new contraindications. This thorough approach supports safe, effective transitions while maintaining treatment momentum.
Complete Your Wegovy Prescription Today
Ready to transition from 5mg Mounjaro to Wegovy? Start with our 3-minute online clinical assessment, designed specifically for patients considering medication switches. New customers apply code FIRST40 at checkout, while returning patients use DOSE25 for optimal pricing. Our GPhC-registered pharmacy (#9012878) ensures pharmaceutical excellence with next-day cold-chain delivery across the UK. Licensed prescribers provide expert guidance throughout your transition, supporting your long-term weight management goals alongside a reduced-calorie diet and increased physical activity. Visit our Wegovy collection to begin your prescription journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
